Literature DB >> 1398067

Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.

E Lees1, B Faha, V Dulic, S I Reed, E Harlow.   

Abstract

Cyclin E is classified as a putative G1 cyclin on the basis of its cyclic pattern of mRNA expression, with maximal levels being detected near the G1/S boundary. We report here that cyclin E is found associated with the transcription factor E2F in a temporally regulated fashion. E2F is known to be a critical transcription factor for the expression of some S phase-specific proteins and is thought to be important for a series of others. Antisera specific for cyclin E were raised and used to demonstrate an association between cyclin E and E2F. This cyclin E/E2F complex was seen in a variety of human cell lines from various tissues, but its appearance was detected primarily during the G1 phase of the cell cycle. The cyclin E/E2F association decreased as cells entered S phase, just as the association of E2F with cyclin A became detectable. We characterized the cyclin E-E2F complex further to show that both the cyclin-dependent kinase-2 (cdk2) and p107 were present. Therefore, the p107/E2F complex is associated with two different cdk2 kinase complexes--one containing cyclin A and the other containing cyclin E--and the appearance of these complexes is temporally regulated during the cell cycle. The presence of cyclin E/E2F complexes in the G1 phase suggests a role for cyclin E in the control of genes required for the G1-to-S transition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398067     DOI: 10.1101/gad.6.10.1874

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  151 in total

1.  Tumor extension and cell proliferation in adenocarcinomas of the lung.

Authors:  M Shoji; Y Dobashi; S Morinaga; S X Jiang; T Kameya
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Differential control of transcription by DNA-bound cyclins.

Authors:  T Y Kim; W G Kaelin
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

3.  Induction of S-phase entry by E2F transcription factors depends on their nuclear localization.

Authors:  H Müller; M C Moroni; E Vigo; B O Petersen; J Bartek; K Helin
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Exploring the functional complexity of cellular proteins by protein knockout.

Authors:  Jianxuan Zhang; Ning Zheng; Pengbo Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

5.  Interactions between human cytomegalovirus IE1-72 and cellular p107: functional domains and mechanisms of up-regulation of cyclin E/cdk2 kinase activity.

Authors:  Zhigang Zhang; Shu-Mei Huong; Xin Wang; David Y Huang; Eng-Shang Huang
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

6.  Stem-cell factor regulates the expression of cyclin A and retinoblastoma gene product in the growth and differentiation pathway of human megakaryocytic cells.

Authors:  E Shimizu; Y Takahashi; A Shinohara; Y Yamamoto; S Yoshida; A Yamamoto; S Sone; Y Takaue; T Ogura
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

7.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Authors:  M Xu; K A Sheppard; C Y Peng; A S Yee; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor.

Authors:  E Castaño; Y Kleyner; B D Dynlacht
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site.

Authors:  A Schulze; K Zerfass; D Spitkovsky; S Middendorp; J Bergès; K Helin; P Jansen-Dürr; B Henglein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.